Sequential use of OnabotulinumtoxinA and Erenumab in Chronic Migraine: Retrospective Real-World Report on Bidirectional Switching

Sadeleştirilmiş öğe sayfası
dc.contributor.authorHoehne, Carolin Luisa
dc.contributor.authorSahin, Aysenur
dc.contributor.authorOvereem, Lucas Hendrik
dc.contributor.authorLange, Kristin Sophie
dc.contributor.authorFitzek, Mira Pauline
dc.contributor.authorAngerhoefer, Cornelius
dc.contributor.authorReuter, Uwe
dc.contributor.authorRaffaelli, Bianca
dc.date.accessioned2025-10-16T15:11:35Z
dc.date.issued2025
dc.identifier.doi10.1007/s40120-025-00803-0
dc.identifier.otherWOS:001541833200001
dc.identifier.urihttps://openaccess.acibadem.edu.tr/handle/11443/4824
dc.publisherSPRINGER LONDON LTD
dc.sourceNEUROLOGY AND THERAPY
dc.subjectErenumab
dc.subjectOnabotulinumtoxinA
dc.subjectCGRP
dc.subjectMigraine
dc.subjectTrigeminovascular system
dc.subjectPain
dc.titleSequential use of OnabotulinumtoxinA and Erenumab in Chronic Migraine: Retrospective Real-World Report on Bidirectional Switching
dc.typeArticle

Dosyalar

Koleksiyonlar

WOS